William Dolphin has agreed to step down as chief executive of biotech company Avita Medical, and Dalton Gooding has resigned after announcing his intention to do so at the company's annual general meeting in November.
11 Dec 2013
Subscribe today for award-winning, unbiased and trusted journalism
